Mason & Associates (California)’s Vertex Pharmaceuticals VRTX Stock Holding History

Mason & Associates (California)’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell
2022 Q2	$309K	Hold
2022 Q1	$286K	Hold
2021 Q4	$241K	Buy